196 related articles for article (PubMed ID: 16061810)
1. HIV binding, penetration, and primary infection in human cervicovaginal tissue.
Maher D; Wu X; Schacker T; Horbul J; Southern P
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11504-9. PubMed ID: 16061810
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues.
Allen SA; Carias AM; Anderson MR; Okocha EA; Benning L; McRaven MD; Kelley ZL; Lurain J; Veazey RS; Hope TJ
J Virol; 2015 May; 89(10):5569-80. PubMed ID: 25740984
[TBL] [Abstract][Full Text] [Related]
3. A model system of oral HIV exposure, using human palatine tonsil, reveals extensive binding of HIV infectivity, with limited progression to primary infection.
Maher D; Wu X; Schacker T; Larson M; Southern P
J Infect Dis; 2004 Dec; 190(11):1989-97. PubMed ID: 15529264
[TBL] [Abstract][Full Text] [Related]
4. Modeling of Virion Collisions in Cervicovaginal Mucus Reveals Limits on Agglutination as the Protective Mechanism of Secretory Immunoglobulin A.
Chen A; McKinley SA; Shi F; Wang S; Mucha PJ; Harit D; Forest MG; Lai SK
PLoS One; 2015; 10(7):e0131351. PubMed ID: 26132216
[TBL] [Abstract][Full Text] [Related]
5. Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study.
Patyka M; Malamud D; Weissman D; Abrams WR; Kurago Z
PLoS One; 2015; 10(7):e0132942. PubMed ID: 26172445
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of monocyte-macrophage-mediated transmission of HIV.
Phillips DM; Tan X; Perotti ME; Zacharopoulos VR
AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S67-70. PubMed ID: 9581887
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of lime juice as a topical microbicide candidate.
Fletcher PS; Harman SJ; Boothe AR; Doncel GF; Shattock RJ
Retrovirology; 2008 Jan; 5():3. PubMed ID: 18190686
[TBL] [Abstract][Full Text] [Related]
8. Sperm can act as vectors for HIV-1 transmission into vaginal and cervical epithelial cells.
Young CD; Tatieng S; Kongmanas K; Fongmoon D; Lomenick B; Yoon AJ; Kiattiburut W; Compostella F; Faull KF; Suree N; Angel JB; Tanphaichitr N
Am J Reprod Immunol; 2019 Jul; 82(1):e13129. PubMed ID: 31066971
[TBL] [Abstract][Full Text] [Related]
9. Selective transmigration of monocyte-associated HIV-1 across a human cervical monolayer and its modulation by seminal plasma.
Lawrence P; Portran D; Terrasse R; Palle S; Olivier T; Fantini J; Bourlet T; Pozzetto B; Delezay O
AIDS; 2012 Apr; 26(7):785-96. PubMed ID: 22495223
[TBL] [Abstract][Full Text] [Related]
10. In vitro models of mucosal HIV transmission.
Shattock RJ; Griffin GE; Gorodeski GI
Nat Med; 2000 Jun; 6(6):607-8. PubMed ID: 10835650
[No Abstract] [Full Text] [Related]
11. Predicting first traversal times for virions and nanoparticles in mucus with slowed diffusion.
Erickson AM; Henry BI; Murray JM; Klasse PJ; Angstmann CN
Biophys J; 2015 Jul; 109(1):164-72. PubMed ID: 26153713
[TBL] [Abstract][Full Text] [Related]
12. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
[TBL] [Abstract][Full Text] [Related]
13. Short communication: genital tumor growth factor-β1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding.
Thakar M; Patil R; Shukre S; Bichare S; Kadam P; Khopkar P; Ghate M; Paranjape R
AIDS Res Hum Retroviruses; 2014 Jul; 30(7):648-53. PubMed ID: 24547777
[TBL] [Abstract][Full Text] [Related]
14. Genital infection of female chimpanzees with human immunodeficiency virus type 1.
Girard M; Mahoney J; Wei Q; van der Ryst E; Muchmore E; Barré-Sinoussi F; Fultz PN
AIDS Res Hum Retroviruses; 1998 Oct; 14(15):1357-67. PubMed ID: 9788677
[TBL] [Abstract][Full Text] [Related]
15. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1.
Hladik F; Sakchalathorn P; Ballweber L; Lentz G; Fialkow M; Eschenbach D; McElrath MJ
Immunity; 2007 Feb; 26(2):257-70. PubMed ID: 17306567
[TBL] [Abstract][Full Text] [Related]
16. Broadly neutralizing antibodies consistently trap HIV-1 in fresh cervicovaginal mucus from select individuals.
Schaefer A; Yang B; Schroeder HA; Harit D; Humphry MS; Ravel J; Lai SK
Acta Biomater; 2023 Oct; 169():387-397. PubMed ID: 37499728
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus.
Lai SK; Hida K; Shukair S; Wang YY; Figueiredo A; Cone R; Hope TJ; Hanes J
J Virol; 2009 Nov; 83(21):11196-200. PubMed ID: 19692470
[TBL] [Abstract][Full Text] [Related]
18. Infection of female primary lower genital tract epithelial cells after natural pseudotyping of HIV-1: possible implications for sexual transmission of HIV-1.
Tang Y; George A; Nouvet F; Sweet S; Emeagwali N; Taylor HE; Simmons G; Hildreth JE
PLoS One; 2014; 9(7):e101367. PubMed ID: 25010677
[TBL] [Abstract][Full Text] [Related]
19. Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasion.
Chen A; McKinley SA; Wang S; Shi F; Mucha PJ; Forest MG; Lai SK
Biophys J; 2014 May; 106(9):2028-36. PubMed ID: 24806935
[TBL] [Abstract][Full Text] [Related]
20. Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells.
Sharkey DJ; Macpherson AM; Tremellen KP; Robertson SA
Mol Hum Reprod; 2007 Jul; 13(7):491-501. PubMed ID: 17483528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
